Skip to main content
رجوع
Watch Compare

INTELLIGENT BIO SOLUTIONS INC.

جودة البيانات: 100%
INBS
Nasdaq Manufacturing Measuring & Analyzing Instruments
KWD 2.52
▼ KWD 0.13 (-4.91%)
القيمة السوقية: 5.04 M
السعر
KWD 2.52
القيمة السوقية
5.04 M
نطاق اليوم
KWD 2.50 — KWD 2.65
نطاق 52 أسبوعًا
KWD 2.46 — KWD 24.90
حجم التداول
26,144
فتح KWD 2.65
متوسط 50 يوم / 200 يوم
KWD 4.92
48.82% below
متوسط 50 يوم / 200 يوم
KWD 10.61
76.24% below

Quick Summary

النقاط الرئيسية

Revenue grew 11.42% annually over 5 years — strong growth
Negative free cash flow of -9.75 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.32%

النمو

Revenue Growth (5Y)
11.42%
أعلى من متوسط القطاع (1.82%)
Revenue (1Y)-1.90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-153.51%
أقل من متوسط القطاع (-53.47%)
ROIC-101.92%
Net Margin-340.03%
Op. Margin-339.91%

الأمان

Debt / Equity
N/A
Current Ratio2.37
Interest Coverage-132.56

التقييم

PE (TTM)
-0.45
أعلى من متوسط القطاع (-1.47)
P/B Ratio0.45
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.5 -1.5
P/B 0.5 1.6
ROE % -153.5 -53.5
Net Margin % -340.0 -41.5
Rev Growth 5Y % 11.4 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -1.90% Revenue Growth (3Y) 55.84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 11.42% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.32 M Net Income (TTM) -11.29 M
ROE -153.51% ROA -81.57%
Gross Margin 49.83% Operating Margin -339.91%
Net Margin -340.03% Free Cash Flow (TTM) -9.75 M
ROIC -101.92% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.37
Interest Coverage -132.56 Asset Turnover 0.24
Working Capital 7.05 M Tangible Book Value 7.82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.45 Forward P/E N/A
P/B Ratio 0.45 P/S Ratio 1.52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -193.34%
Market Cap 5.04 M Enterprise Value 4.30 M
Per Share
EPS (Diluted TTM) -7.09 Revenue / Share 1.66
FCF / Share -4.87 OCF / Share -4.69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 11.15% FCF Conversion 86.33%
SBC-Adj. FCF -10.04 M Growth Momentum -13.32

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.05 M 3.11 M 1.26 M 437,146.0 1.98 M
Net Income -10.57 M -10.16 M -10.63 M -8.31 M -7.04 M
EPS (Diluted) -2.00 -6.38 -10.58 — —
Gross Profit 1.25 M 1.43 M 326,668.0 — —
Operating Income -10.64 M -10.28 M -12.60 M -8.34 M -5.57 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 970,117.0 974,355.0 814,481.0 — —
Interest Expense 60,890.0 — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.25 M 13.78 M 10.35 M 12.35 M 21.86 M
Total Liabilities 5.44 M 5.60 M 6.67 M 5.81 M 6.85 M
Shareholders' Equity 3.00 M 8.33 M 3.80 M 6.62 M 15.06 M
Total Debt 1.65 M 1.65 M — — —
Cash & Equivalents 1.02 M 6.30 M 1.54 M 8.24 M 12.57 M
Current Assets 4.14 M 8.53 M 3.86 M 10.87 M 18.21 M
Current Liabilities 5.35 M 5.45 M 5.88 M 4.66 M 3.68 M